These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33763071)

  • 1. Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients.
    Germain C; Devi-Marulkar P; Knockaert S; Biton J; Kaplon H; Letaïef L; Goc J; Seguin-Givelet A; Gossot D; Girard N; Validire P; Lefèvre M; Damotte D; Alifano M; Lemoine FM; Steele KE; Teillaud JL; Hammond SA; Dieu-Nosjean MC
    Front Immunol; 2021; 12():626776. PubMed ID: 33763071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer.
    Xin S; Wen S; He P; Zhao Y; Zhao H
    Front Immunol; 2024; 15():1423775. PubMed ID: 39192984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.
    Goc J; Germain C; Vo-Bourgais TK; Lupo A; Klein C; Knockaert S; de Chaisemartin L; Ouakrim H; Becht E; Alifano M; Validire P; Remark R; Hammond SA; Cremer I; Damotte D; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
    Cancer Res; 2014 Feb; 74(3):705-15. PubMed ID: 24366885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring.
    Berthe J; Poudel P; Segerer FJ; Jennings EC; Ng F; Surace M; Andoni A; Testori M; Saraiya M; Vuko M; Hessel H; Heininen-Brown M; Blando J; Jones EV; Willis SE; Galon J; van de Ven R; de Gruijl TD; Angell HK
    Front Immunol; 2024; 15():1422206. PubMed ID: 39376565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC.
    Devi-Marulkar P; Fastenackels S; Karapentiantz P; Goc J; Germain C; Kaplon H; Knockaert S; Olive D; Panouillot M; Validire P; Damotte D; Alifano M; Murris J; Katsahian S; Lawand M; Dieu-Nosjean MC
    Commun Biol; 2022 Dec; 5(1):1416. PubMed ID: 36566320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-Presenting Intratumoral B Cells Affect CD4
    Bruno TC; Ebner PJ; Moore BL; Squalls OG; Waugh KA; Eruslanov EB; Singhal S; Mitchell JD; Franklin WA; Merrick DT; McCarter MD; Palmer BE; Kern JA; Slansky JE
    Cancer Immunol Res; 2017 Oct; 5(10):898-907. PubMed ID: 28848053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma.
    Siliņa K; Soltermann A; Attar FM; Casanova R; Uckeley ZM; Thut H; Wandres M; Isajevs S; Cheng P; Curioni-Fontecedro A; Foukas P; Levesque MP; Moch H; Linē A; van den Broek M
    Cancer Res; 2018 Mar; 78(5):1308-1320. PubMed ID: 29279354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products.
    Castenmiller SM; Kanagasabesan N; Guislain A; Nicolet BP; van Loenen MM; Monkhorst K; Veenhof AAFA; Smit EF; Hartemink KJ; Haanen JBAG; de Groot R; Wolkers MC
    Oncoimmunology; 2024; 13(1):2392898. PubMed ID: 39188755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Cell Composition in Human Non-small Cell Lung Cancer.
    Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Front Immunol; 2018; 9():3101. PubMed ID: 30774636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.
    Ganesan AP; Johansson M; Ruffell B; Yagui-Beltrán A; Lau J; Jablons DM; Coussens LM
    J Immunol; 2013 Aug; 191(4):2009-17. PubMed ID: 23851682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
    Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
    Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.
    Germain C; Gnjatic S; Tamzalit F; Knockaert S; Remark R; Goc J; Lepelley A; Becht E; Katsahian S; Bizouard G; Validire P; Damotte D; Alifano M; Magdeleinat P; Cremer I; Teillaud JL; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
    Am J Respir Crit Care Med; 2014 Apr; 189(7):832-44. PubMed ID: 24484236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer.
    Di Modugno F; Di Carlo A; Spada S; Palermo B; D'Ambrosio L; D'Andrea D; Morello G; Belmonte B; Sperduti I; Balzano V; Gallo E; Melchionna R; Panetta M; Campo G; De Nicola F; Goeman F; Antoniani B; Carpano S; Frigè G; Warren S; Gallina F; Lambrechts D; Xiong J; Vincent BG; Wheeler N; Bortone DS; Cappuzzo F; Facciolo F; Tripodo C; Visca P; Nisticò P
    EBioMedicine; 2024 Mar; 101():105003. PubMed ID: 38340557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients.
    Cai S; Zhao M; Yang G; Li C; Hu M; Yang L; Xing L; Sun X
    Int Immunopharmacol; 2024 Aug; 137():112434. PubMed ID: 38889507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
    Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
    Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.
    Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K
    J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.
    Fukuhara M; Muto S; Inomata S; Yamaguchi H; Mine H; Takagi H; Ozaki Y; Watanabe M; Inoue T; Yamaura T; Okabe N; Matsumura Y; Hasegawa T; Osugi J; Hoshino M; Higuchi M; Shio Y; Suzuki H
    Cancer Immunol Immunother; 2022 May; 71(5):1129-1137. PubMed ID: 34596720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.
    Dieu-Nosjean MC; Giraldo NA; Kaplon H; Germain C; Fridman WH; Sautès-Fridman C
    Immunol Rev; 2016 May; 271(1):260-75. PubMed ID: 27088920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.